Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis.
Department of Pediatrics, Section of Pediatric Dermatology, The Children's Hospital of Philadelphia, and The University of Pennsylvania Perlman School of Medicine, Philadelphia, Pennsylvania. Electronic address: castelosocciol@email.chop.edu.
Leslie
L
Castelo-Soccio
D000284:Administration, Oral; D000293:Adolescent; D000505:Alopecia / Q000188:drug therapy*; D002648:Child; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D053613:Janus Kinase 1 / Q000037:antagonists & inhibitors*; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
D003879:Dermatologic Agents; D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; C479163:tofacitinib; D053613:Janus Kinase 1